Corporate Banner
Satellite Banner
Proteomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

EU Research Grants Awarded to Three of Karolinska Development’s Portfolio Companies

Published: Monday, December 30, 2013
Last Updated: Monday, December 30, 2013
Bookmark and Share
Goal is to develop new ways to treat infectious diseases.

Karolinska Development has announced that its portfolio companies Pergamum, Inhalation Sciences Sweden (ISS) and XSpray Microparticles have been awarded research grants totaling more than EUR 1 million within the framework of the international research project FORMAMP.

The goal is to develop new ways to treat infectious diseases in order to reduce the problem of antibiotic resistance.

"The three portfolio companies are engaged in potentially pioneering activities in the antiinfective area - Pergamum’s antimicrobial peptide DPK-060 has been documented in a Phase II clinical trial and both XSpray and ISS develop technologies to transport drug substances to the right place in the body. The EU project provides us with increased opportunities to exploit synergies between the involved companies' knowledge and projects", says Torbjörn Bjerke, CEO of Karolinska Development.

In the EU project FORMAMP (Innovative Nano Formulation of Antimicrobial Peptides to Treat Bacterial Infectious Diseases), a team of researchers, coordinated by the SP Technical Research Institute of Sweden, will develop new strategies for the treatment of infections.

A total of 16 partners are engaged in the project, which has a total budget of over EUR 10 million and runs over four years.

Karolinska Development’s portfolio company Pergamum has been allocated EUR 250,000, ISS EUR 384,000 and XSpray Microparticles EUR 401,000. The project was launched at a kick-off meeting in Stockholm on December 12, 2013.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Detecting Alzheimer's with Smell Test
Odour identification test may offer low-cost alternative for predicting cognitive decline and detecting early-stage Alzheimer’s disease.
Fighting Cancer Through Protein Pathways
Researchers have found a new drug target within a protein production pathway critical to regulating growth and proliferation of cells.
Uncovering Rhinovirus C Structure
Researchers have determined the structure of rhinovirus C. Their findings may aid the development of antiviral therapies and vaccines.
New Centre Offers Ultra-Speed Protein Analysis
UW-Madison researchers to establish development centre for next-gen protein measurement technologies.
Protein Nanocages Could Improve Drug Design and Delivery
HHMI scientists have designed and built 10 large protein icosahedra that are similar to viral capsids that carry viral DNA.
Virus Inspired Cell Cargo Ships
Virus-inspired container design may lead to cell cargo ships following construction of ten large, two-component, icosahedral protein complexes.
Protein Reinforces Growth of Damaged Muscles
Biologists have found a protein involved in stem cells that bolsters damaged muscle tissue growth - potential for muscle degeneration treatments.
Structure of Cold Virus Solved
Researchers have identified the structure of an elusive cold virus linked to child asthma and respiratory infections, providing the foundation for treating the virus.
New Protein Model Could Accelerate Drug Development
Stony Brook-led international research team creates ultra-fast approach to model protein interactions.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!